Terapia farmacológica para redução do risco cardiovascular no portador de diabetes

Machado, AR; Hygidio, DA; Lisboa, HMF; Bruscky, LRV; Soares, OC; Boretti, VS; Bertolami, MC; Sulzbach, ML.
São Paulo; 2017. 77 p.
Português | DANTEPAZZANESE, SES SP - Acervo Instituto Dante Pazzanese de Cardiologia | ID: dan-4261

Documentos relacionados

  1. [Hospital medication adherence scale development in cardiovascular disorders].
  2. Letter by Atienza et al Regarding Article, "Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now".
  3. The Year in Cardiovascular Medicine 2020: Imaging.
  4. Polypill for prevention of cardiovascular diseases - Authors' reply.
  5. The year in cardiovascular medicine 2021: dyslipidaemia.
  6. The Price of Progress: Cost, Access, and Adoption of Novel Cardiovascular Drugs in Clinical Practice.
  7. Wearable Devices in Cardiovascular Medicine.
  8. Response by Thiene and Saffitz to Letter Regarding Article, "Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now".
  9. The manual of cardiovascular medicine, Oxford University Press 2022: just a pocket guide but 'all inclusive'.
  10. A polypill for cardiovascular disease prevention with a focus on non-alcohol steatohepatitis.